Dosimetric effect of respiratory motion in external beam radiotherapy of the lung.

BACKGROUND AND PURPOSE To study the effect of breathing motion on gross tumor volume (GTV) coverage for lung tumors using dose-volume histograms and relevant dosimetric indices. PATIENTS AND METHODS Treatment plans were chosen for 12 patients treated at our institution for lung carcinoma. GTV volumes of these patients ranged from 1.2 to 97.3 cm(3). A margin of 1-2 cm was used to generate the planning target volume (PTV). Additional margins of 0.6-1.0 cm were added to the PTV when designing treatment portals. For the purposes of TCP calculation, the prescription dose was assumed to be 70 Gy to remove the effects of prescription differences. Setup error was incorporated into the evaluation of treatment plans with a systematic component of sigma(RL) = 0.2 cm, sigma(AP) = 0.2 cm, and sigma(SI) = 0.3 cm and a random component of sigma(RL) = 0.3 cm, sigma(AP) = 0.3 cm, and sigma(SI) = 0.3 cm. Breathing motion was incorporated into these plans based on an independent analysis of fluoroscopic movies of the diaphragm for 7 patients. The systematic component of breathing motion (sigma(RL) = 0.3 cm, sigma(AP) = 0.2 cm, and sigma(SI) = 0.6 cm) was incorporated into the treatment plans on a slice by slice basis. The intrafractional component of breathing motion (sigma(RL) = 0.3 cm, sigma(AP) = 0.2 cm, and sigma(SI) = 0.6 cm) was incorporated by averaging the dose calculation over all displacements of the breathing cycle. Each patient was simulated 500 times to discern the range of possible outcomes. The simulations were repeated for a worst case scenario which used only breathing data with a large diaphragmatic excursion, both with and without intrafractional breathing motion. RESULTS Dose to 95% of the GTV (D95), volume of the GTV receiving 95% of the prescription dose (V95) and TCP changed an average of -1.4+/-4.2, -1.0+/-3.3, and -1.4+/-3.8%, respectively, with the incorporation of normal breathing effects. In the worst case scenario (heavy breathers), D95 and V95 changed an average of -9.8+/-10.1 and -8.3+/-11.3%, respectively, and TCP changed by -8.1+/-9.1%. GTVs with volumes greater than 60 cm(3) showed stronger sensitivity to breathing especially if the shape was non-ellipsoidal. In the normal breathing case, the probability of a decrease in D95, V95, or TCP of a magnitude greater than 10% is less than 4%, and in the worse case scenario this probability is approximately 30-40% with intrafractional breathing motion included, and less than 10% with intrafractional breathing motion not included. CONCLUSIONS With the PTV margins routinely used at our center, the effects of normal breathing on coverage are small on the average, with a less than 4% chance of a 10% or greater decrease in D95, V95, or TCP. However, in patients with large respiration-induced motion, the effect can be significant and efforts to identify such patients are important.

[1]  M. Martel,et al.  Volume and dose parameters for survival of non-small cell lung cancer patients. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  R. Mohan,et al.  Use of fast Fourier transforms in calculating dose distributions for irregularly shaped fields for three-dimensional treatment planning. , 1987, Medical physics.

[3]  H Shirato,et al.  Detection of lung tumor movement in real-time tumor-tracking radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[4]  H Shirato,et al.  Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[5]  J C Rosenwald,et al.  Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.

[6]  C. Ling,et al.  Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. , 2000, International journal of radiation oncology, biology, physics.

[7]  C. Chui,et al.  A patient-specific Monte Carlo dose-calculation method for photon beams. , 1998, Medical physics.

[8]  R K Ten Haken,et al.  Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.

[9]  E. Larsen,et al.  A method for incorporating organ motion due to breathing into 3D dose calculations. , 1999, Medical physics.

[10]  W. Stanford,et al.  Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.

[11]  G Starkschall,et al.  Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. , 2001, International journal of radiation oncology, biology, physics.

[12]  S Senan,et al.  An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer. , 1999, International journal of radiation oncology, biology, physics.

[13]  D Verellen,et al.  Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation. , 1998, International journal of radiation oncology, biology, physics.

[14]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[15]  T. Landberg,et al.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  K. Lam,et al.  Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. , 1996, International journal of radiation oncology, biology, physics.

[17]  M Engelsman,et al.  The effect of breathing and set-up errors on the cumulative dose to a lung tumor. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Gikas S. Mageras,et al.  Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system , 2001, Journal of applied clinical medical physics.

[19]  Joos V Lebesque,et al.  Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. , 2001, Radiotherapy and Oncology.

[20]  R D Zwicker,et al.  Transverse tomosynthesis on a digital simulator. , 1997, Medical physics.

[21]  R Mohan,et al.  A comprehensive three-dimensional radiation treatment planning system. , 1988, International journal of radiation oncology, biology, physics.

[22]  Marcel van Herk,et al.  Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  J. Bradley,et al.  Preliminary results of a radiation therapy oncology group trial (RTOG 9311), a dose escalation study using 3d conformal radiation therapy in patients with inoperable nonsmall cell lung cancer , 2001 .

[24]  Kurt Baier,et al.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.